• Citer

Characterisation of the HLA-DRB107:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

par Spraggs, Colin C.F.;Parham, Laura L.R.;Briley, Linda L.P.;Warren, Liling;Williams, Laura L.S.;Fraser, Dana D.J.;Jiang, Zefei;Aziz, Zeba;Ahmed, Shahjehan;Demetriou, Georgia;Mehta, Ajay A.O.;Jackson, Nigel;Byrne, Julie;Andersson, Michael;Toi, Masakazu;Harris, Lyndsay;Gralow, Julie;Zujewski, Jo Anne;Crescenzo, R.;Armour, Alison;Perez, Enrique;Piccart-Gebhart, Martine
Référence Pharmacogenomics journal, 18, 3, page (480-486)
Publication Publié, 2018-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Characterisation of the HLA-DRB107:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes
Auteur:	Spraggs, Colin C.F.; Parham, Laura L.R.; Briley, Linda L.P.; Warren, Liling; Williams, Laura L.S.; Fraser, Dana D.J.; Jiang, Zefei; Aziz, Zeba; Ahmed, Shahjehan; Demetriou, Georgia; Mehta, Ajay A.O.; Jackson, Nigel; Byrne, Julie; Andersson, Michael; Toi, Masakazu; Harris, Lyndsay; Gralow, Julie; Zujewski, Jo Anne; Crescenzo, R.; Armour, Alison; Perez, Enrique; Piccart-Gebhart, Martine
Informations sur la publication:	Pharmacogenomics journal, 18, 3, page (480-486)
Statut de publication:	Publié, 2018-05
Sujet CREF:	Biologie
	Biologie moléculaire
	Pharmacologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1470-269X
	info:doi/10.1038/tpj.2017.39
	info:scp/85047642319